Merck Sues Over Medicare Drug-Price Negotiation Law

Start

The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.

Previous Story

A Reporter Investigated Sexual Misconduct. Then the Attacks Began.

Next Story

SEC Sues Coinbase, Accuses Crypto Platform of Breaking Market Rules